Cargando…
A Network Meta-Analysis of Cancer Immunotherapies Versus Chemotherapy for First-Line Treatment of Patients With Non-Small Cell Lung Cancer and High Programmed Death-Ligand 1 Expression
In the absence of head-to-head trials of first-line treatments for metastatic non-small cell lung cancer (NSCLC), synthesis of available evidence is needed. We conducted a systematic literature review and network meta-analysis of randomized controlled trials in patients with stage IV NSCLC and high...
Autores principales: | Herbst, Roy, Jassem, Jacek, Abogunrin, Seye, James, Daniel, McCool, Rachael, Belleli, Rossella, Giaccone, Giuseppe, De Marinis, Filippo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300186/ https://www.ncbi.nlm.nih.gov/pubmed/34307144 http://dx.doi.org/10.3389/fonc.2021.676732 |
Ejemplares similares
-
Systematic Literature Review to Identify Cost and Resource Use Data in Patients with Early-Stage Non-small Cell Lung Cancer (NSCLC)
por: Jovanoski, Nick, et al.
Publicado: (2023) -
Survival and quality-of-life outcomes in early-stage NSCLC patients: a literature review of real-world evidence
por: Jovanoski, Nick, et al.
Publicado: (2023) -
Treatment patterns and survival of patients with locoregional recurrence in early-stage NSCLC: a literature review of real-world evidence
por: Bowes, Kathleen, et al.
Publicado: (2022) -
Health State Utility Values in Early-Stage Non-small Cell Lung Cancer: A Systematic Literature Review
por: Jovanoski, Nick, et al.
Publicado: (2023) -
The Role of Immunotherapy or Immuno-Chemotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review
por: Mohamed, Shehab, et al.
Publicado: (2023)